Labcorp Holdings Inc. (0JSY.L)

205.52 -1.52 (-0.74%) At close: 05:46PM BST

Labcorp Holdings Inc.

358 South Main Street
Burlington, NC 27215
United States
336 229 1127
https://www.labcorp.com

Sector(s): 
Industry: 
Full-time employees: 67,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Adam H. Schechter	President, CEO & Chairman	4.66M	N/A	1965
Mr. Glenn A. Eisenberg	CFO & Executive VP	1.87M	N/A	1961
Mr. Mark S. Schroeder	Executive VP, President of Diagnostics Laboratories & COO	1.43M	129.25k	1961
Dr. Brian J. Caveney J.D., M.D., M.P.H.	EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer	1.3M	N/A	1974
Ms. Anita Z. Graham	Executive VP & Chief Human Resources Officer	1.35M	N/A	1971
Mr. Lance V. Berberian	Executive VP and Chief Information & Technology Officer	876.62k	N/A	1963
Christin O'Donnell	Vice President of Investor Relations	N/A	N/A	N/A
Ms. Sandra D. van der Vaart	Executive VP, Chief Legal Officer & Corporate Secretary	N/A	N/A	1960
Dr. Deborah Ann Sesok-Pizzini	Chief Medical Officer, SVP of Labcorp Diagnostics & Discipline Director of Immunohematology	N/A	N/A	N/A
Mr. Jonathan P. DiVincenzo	Executive VP and President of Central Laboratories & International	N/A	N/A	1966

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Labcorp Holdings Inc. operates as a laboratory services company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers.

Corporate governance

Labcorp Holdings Inc.’s ISS governance QualityScore as of 1 May 2024 is 3. The pillar scores are Audit: 6; Board: 7; Shareholder rights: 1; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.